手术脑室进入对IDH突变型胶质瘤生存结局的影响
回顾性分析2006至2021年匹兹堡大学医学中心231例幕上IDH突变型胶质瘤患者,32.9%发生脑室进入。脑室进入与室管膜下强化、软脑膜病变及远处新发病灶增加相关,并独立降低总生存和无进展生存。
要点
- 脑室进入是IDH突变型胶质瘤总生存和无进展生存的独立危险因素。
- 脑室进入与室管膜下强化、软脑膜病变及远处新发病灶增加相关。
- 需前瞻性研究评估脑室进入的风险、获益及缓解策略。
核心结论
- 脑室进入与IDH突变型胶质瘤较差的生存结局相关。
研究设计与样本
- 回顾性分析2006至2021年匹兹堡大学医学中心231例幕上IDH突变型胶质瘤患者,通过术后影像识别脑室进入。
主要发现
- 脑室进入发生率为32.9%(76例),研究期间64.9%患者疾病进展,42.4%死亡。
- 脑室进入与室管膜下/室管膜强化率更高相关(18.4% vs 3.2%,P < .001)。
- 脑室进入与软脑膜病变率更高相关(6.6% vs 0.6%,P = .02)。
- 脑室进入与远处新发病灶率更高相关(18.4% vs 5.8%,P = .006)。
- 多变量分析调整临床、病变、分子因素及室下区接触后,脑室进入是总生存(HR: 2.1 [1.24-3.48],P = .005)和无进展生存(HR: 1.66 [1.13-2.44],P = .01)降低的独立危险因素。
临床怎么用
- 在IDH突变型胶质瘤手术中应认识脑室进入与不良生存的关联,并权衡其风险与获益。
局限性
- 本研究为回顾性分析,需前瞻性研究进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Although some studies suggest ventricular entry (VE) is associated with complications and poor survival in glioblastoma, it remains unclear whether this association applies to isocitrate dehydrogenase (IDH)-mutant gliomas. This study evaluated the impact of VE on progression-free survival (PFS) and overall survival (OS) in these tumors. METHODS: A retrospective analysis of patients with supratentorial IDH-mutant gliomas, treated between 2006 and 2021 at the University of Pittsburgh Medical Center was performed. VE was identified through postoperative imaging review. RESULTS: A total of 231 patients were identified, with VE occurring in 32.9% (n = 76) of patients. During the study period, 64.9% of patients experienced disease progression, and 42.4% died. VE was associated with a higher rate of subependymal/ependymal enhancement (18.4% vs 3.2%, P < .001), leptomeningeal disease (6.6% vs 0.6%, P = .02) and, new distant foci development (18.4% vs 5.8% P = .006), shorter median OS ( P [log-rank] <0.0001), and shorter median PFS ( P < .0001). Multivariable analysis identified VE as an independent risk factor of decreased OS (HR: 2.1 [1.24-3.48], P = .005) and PFS (HR: 1.66 [1.13-2.44], P = .01), after adjusting for clinical, lesional, molecular factors, and subventricular zone contact. CONCLUSION: This study indicates that VE is associated with poor survival outcomes in IDH-mutant gliomas. These findings warrant prospective studies to better understand the risks, benefits, and mitigation strategies of VE in glioma surgery. Understanding the ependymal physical barrier as well as, cellular biological effects of VE, and its role in glioma tumorigenesis may serve as a basis for potential therapeutic targets in the future management of these patients.
引用
- Gecici NN, Habib A, Drappatz J, et al. Impact of Surgical Ventricular Entry on Survival Outcomes in IDH-Mutant Gliomas. Neurosurgery. 2025. PMID: 40965154. doi:10.1227/neu.0000000000003744
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。